The pilot program will run from July 1, 2026, through December 31, 2027
Noom discloses pharmacy details on request, and its compounded medication is sourced through state-regulated pharmacies
Regular monitoring during treatment helps healthcare providers adjust dosing as needed while maintaining safety
Samols E, Weir GC (1979) Adrenergic modulation of pancreatic A, B, and D cells alpha-adrenergic suppression and beta-adrenergic stimulation of somatostatin secretion, alpha-adrenergic stimulation of glucagon secretion in the perfused dog pancreas
Our data indicate that GLP-1RA/tesaglitazar might hold therapeutic value for conditions characterized by hyperglycaemia and insulin resistance
Similar to other medications containing semaglutide, there are no documented contraindications